Company Filing History:
Years Active: 2024
Title: Yi Na Yoon: Innovator in Cancer Treatment
Introduction
Yi Na Yoon is a prominent inventor based in Incheon, South Korea. He has made significant contributions to the field of cancer treatment through his innovative research and development of pharmaceutical compositions. His work focuses on creating effective solutions for preventing and treating cancer.
Latest Patents
Yi Na Yoon holds a patent for a pharmaceutical composition aimed at preventing or treating cancer. The patent, titled "Pharmaceutical composition for preventing or treating cancer, containing N-1H-benzimidazol-2-yl-3-(1H-pyrrole-1-yl)benzamide as active ingredient," describes a composition that includes N-1H-benzimidazol-2-yl-3-(1H-pyrrol-1-yl) benzamide or its derivatives. This composition is designed to arrest the mitosis of cancer cells, thereby preventing their proliferation while exhibiting low toxicity in normal cell lines. Additionally, it induces apoptosis specifically in cancer cell lines, making it a promising anticancer agent. Furthermore, the composition enhances the sensitivity of treated cancer cells to radiation, positioning it as a potential radiosensitizer for cancer treatment.
Career Highlights
Yi Na Yoon is affiliated with the Korea Institute of Radiological and Medical Sciences, where he conducts his research. His work has garnered attention for its potential impact on cancer therapies and patient outcomes. With a focus on innovative solutions, he continues to push the boundaries of cancer treatment.
Collaborations
Yi Na Yoon collaborates with notable colleagues, including Jae Sung Kim and Ah Young Kim. Their combined expertise contributes to the advancement of research in the field of oncology.
Conclusion
Yi Na Yoon's contributions to cancer treatment through his innovative pharmaceutical compositions highlight the importance of research in developing effective therapies. His work not only addresses the challenges of cancer proliferation but also enhances treatment efficacy through radiosensitization.